Presented by John S Roth, MD at the SS06: Ventral Hernias held during the 2017 SAGES Annual Meeting in Houston, TX on Thursday, March 23, 2017
Keyword(s): absorbable mesh, adhesiolysis, adverse events, allcomers trial, BMI, body mass index, burst strength, C.R. Bard, cardiovascular comorbidities, CDC class I, chronic pain, class II wound, class III wound, complication, component separation, concomitant, contamination, COPD, diabetes, efficacy, emergent, follow-up, gold standard, hernia defect, hernia recurrence, high risk, immunosuppression, in vitro degredation study, iventral and ncisional hernia repair, mesh contraction, mesh erosion, mesh infection, mesh removal, midline laparotomy, morbidly obese, onlay, operative time, pain score, permanent mesh, physical exam, physical examination, poly-4-hydroxybutyrate mesh, primary endpoints, prospective evaluation, recurrence rate, renal insufficiency, reoperation, retrorectus repair, secondary endpoints, seroma, SSI, surgical site infection, surgical time, synthetic mesh, TAR, transversus abdominis release, umbilical hernias, VAS, ventral hernias, Visual analog scale
Incisional hernia overview–19 sec
Synthetic mesh–44 sec Arch Surg 1998
Absorbable mesh–1:11
In vitro degredation study–1:51 J Surg Res 2013
Study design—2:19
Inclusion criteria–2:35
Exclusion criteria–3:17
Primary endpoints–3:33
Secondary endpoints–3:56
Demographics–4:15
Results–5:39
Conclusion–6:27
Q&A session–6:50